EULAV Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,400
Closed -$352K 190
2023
Q1
$352K Sell
3,400
-3,400
-50% -$377K 0.01% 192
2022
Q4
$784K Hold
6,800
0.03% 191
2022
Q3
$737K Sell
6,800
-13
-0.2% -$1.86K 0.03% 193
2022
Q2
$1.23M Buy
6,813
+399
+6% +$71.4K 0.05% 193
2022
Q1
$1.09M Buy
6,414
+2
+0% +$377 0.03% 210
2021
Q4
$1.38M Buy
6,412
+1
+0% +$207 0.03% 211
2021
Q3
$1.24M Hold
6,411
0.03% 208
2021
Q2
$1.81M Hold
6,411
0.05% 200
2021
Q1
$1.36M Hold
6,411
0.04% 220
2020
Q4
$1.26M Buy
6,411
+11
+0.2% +$1.94K 0.03% 227
2020
Q3
$1.05M Sell
6,400
-16
-0.2% -$2.63K 0.03% 231
2020
Q2
$890K Buy
6,416
+16
+0.3% +$1.47K 0.03% 237
2020
Q1
$400K Sell
6,400
-6,200
-49% -$564K 0.02% 246
2019
Q4
$1.38M Sell
12,600
-5,700
-31% -$552K 0.05% 234
2019
Q3
$1.9M Hold
18,300
0.07% 219
2019
Q2
$2.35M Buy
18,300
+6,900
+61% +$959K 0.09% 201
2019
Q1
$1.49M Hold
11,400
0.06% 227
2018
Q4
$1.43M Hold
11,400
0.07% 215
2018
Q3
$2.53M Hold
11,400
0.11% 178
2018
Q2
$1.83M Buy
11,400
+900
+9% +$115K 0.08% 201
2018
Q1
$981K Buy
+10,500
New +$785K 0.05% 228

Other funds holding MED